Abstract:Pancreatic adenocarcinoma is the most lethal of the solid tumors and the fourth-leading cause of cancer-related death in North America. Matrix metalloproteinases (MMPs) have long been targeted as a potential anticancer therapy because of their seminal role in angiogenesis and extracellular matrix (ECM) degradation of tumor survival and invasion. However, the inhibition specificity to MMPs and the molecular-level understanding of the inhibition mechanism remain largely unresolved. Here, we found that endohedral metallofullerenol Gd@C 82 (OH) 22 can successfully inhibit the neoplastic activity with experiments at animal, tissue, and cellular levels. Gd@C 82 (OH) 22 effectively blocks tumor growth in human pancreatic cancer xenografts in a nude mouse model. Enzyme activity assays also show Gd@C 82 (OH) 22 not only suppresses the expression of MMPs but also significantly reduces their activities. We then applied large-scale molecular-dynamics simulations to illustrate the molecular mechanism by studying the Gd@C 82 (OH) 22 –MMP-9 interactions in atomic detail. Our data demonstrated that Gd@C 82 (OH) 22 inhibits MMP-9 mainly via an exocite interaction, whereas the well-known zinc catalytic site only plays a minimal role. Steered by nonspecific electrostatic, hydrophobic, and specific hydrogen-bonding interactions, Gd@C 82 (OH) 22 exhibits specific binding modes near the ligand-specificity loop S1′, thereby inhibiting MMP-9 activity. Both the suppression of MMP expression and specific binding mode make Gd@C 82 (OH) 22 a potentially more effective nanomedicine for pancreatic cancer than traditional medicines, which usually target the proteolytic sites directly but fail in selective inhibition. Our findings provide insights for de novo design of nanomedicines for fatal diseases such as pancreatic cancer.

Metallofullerol Nanoparticles with Low Toxicity Inhibit Tumor Growth by Induction of G0/G1 Arrest (retracted Article. See Vol. 8, Pg. 1356, 2013)

RETRACTED: Metallofullerol nanoparticles with low toxicity inhibit tumor growth by induction of G0/G1 arrest (Retracted article. See vol. 8, pg. 1356, 2013)

Gd-metallofullerenol Nanomaterial As Non-Toxic Breast Cancer Stem Cell-Specific Inhibitor

Multi Hydroxylated [Gd@c-82(Oh)(22)](n) Nanoparticles: Antineoplastic Activity of High Efficiency and Low Toxicity

Inhibition of CYP2C8 by Metallofullerenol Gd@C82(OH)22 Through Blocking Substrate Channels and Substrate Recognition Sites

The Effect of Gd@C-82(Oh)(22) Nanoparticles on the Release of Th1/Th2 Cytokines and Induction of Tnf-Alpha Mediated Cellular Immunity

Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis.

Inhibition of Tumor Growth by Endohedral Metallofullerenol Nanoparticles Optimized As Reactive Oxygen Species Scavenger.

[Gd@C-82(Oh)(22)](N) Nanoparticles Inhibit The Migration And Adhesion Of Glioblastoma Cells

Antineoplastic activities of Gd@C82(OH)22 nanoparticles: tumor microenvironment regulation

Dual Inhibitory Pathways of Metallofullerenol Gd@C82(OH)22 on Matrix Metalloproteinase-2: Molecular Insight into Drug-Like Nanomedicine

Eliminating Active Species by Endohedral Metallofullerenol in Vitro and in Vivo

Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice.

Photo-triggered Gadofullerene: Enhanced Cancer Therapy by Combining Tumor Vascular Disruption and Stimulation of Anti-Tumor Immune Responses

A Novel Bone Marrow Targeted Gadofullerene Agent Protect Against Oxidative Injury in Chemotherapy

Molecular Mechanism of Gd@C82(OH)22 Increasing Collagen Expression: Implication for Encaging Tumor

Nanoparticle Gd@C_(82)(OH)_(22) Inhibits the Efflux Transporter of Mammalian Cells

The pharmaceutical multi-activity of metallofullerenol invigorates cancer therapy

Molecular Mechanism of Pancreatic Tumor Metastasis Inhibition by Gd@C82(OH)22 and Its Implication for De Novo Design of Nanomedicine.

Subcellular distribution of polyhydroxylated metallofullerene Gd@C 82(OH) 22 in different tissues of tumor-bearing mice

Gd@C82(OH)22 Nanoparticles Constrain Macrophages Migration into Tumor Tissue to Prevent Metastasis.